Bird & Bird is one of the world's leading IP specialist firms.
Its Sydney office has a growing IP team, led by Jane Owen, which focuses particularly in complex IP contentious work.
The global Bird & Bird IP team has over 300 specialised lawyers in 28 offices and is one of the most respected IP teams in the world, recently being named Europe's IP Law Firm of the Decade. As part of this international powerhouse, we continue to be involved in high value patent litigation matters (eg representing Korean company Dongkuk Steel against BlueScope).
2016 has delivered the Australian IP team notable wins – eg - A high profile pharma patent litigation matter of Otsuka v Generic Health in which we successfully represented Generic Health in revoking Otsuka's method of treatment patent for aripiprazole (Abilify™).
We successfully represented vet pharma companies and the industry body (VMDA) in the Federal Court, challenging the position adopted by the regulator not to consider originator formulation information when reviewing applications for registration of generic vet pharma formulations.
In 2016 our Sydney team advised clients such as Vodafone, UNSW, University of Wollongong, Mattel, Teva Pharmaceuticals, Union Steel and Veda Advantage as well as clients across a range of industries, such as technology, IT, fashion, advertising and pharmaceutical.
2016 saw Bird & Bird handling cutting edge trade mark and ACL matters – protecting the shape of the EOS lip balm in Federal Court proceedings and obtaining protection for its shape as a registered trade mark.